Using Cefuroxime to Prevent Eye Infections After Cataract Surgery
Author Information
Author(s): Barry P, Seal DV, Gettinby G, Lees F, Peterson M, Revie CW
Primary Institution: International Centre for Eye Health
Hypothesis
Does intracameral cefuroxime injection reduce the incidence of endophthalmitis after cataract surgery?
Conclusion
Intracameral cefuroxime administered at the time of surgery significantly reduced the risk for developing endophthalmitis after cataract surgery.
Supporting Evidence
- The incidence of endophthalmitis was almost five times higher in patients not receiving cefuroxime.
- Out of 10,000 cataract operations without cefuroxime, 23.3 would be expected to develop endophthalmitis.
- With cefuroxime, this number would only be 4.4.
- Globally, 10 million cataract operations are performed every year, leading to an estimated 23,000 cases of endophthalmitis.
Takeaway
Giving a special medicine called cefuroxime during cataract surgery helps prevent a serious eye infection. It’s like putting on a raincoat to stay dry when it rains.
Methodology
This was a partially masked randomized placebo-controlled multinational clinical study evaluating the prophylactic effect of intracameral cefuroxime and/or perioperative levofloxacin eyedrops.
Potential Biases
The study was conducted in Europe, and results may differ in developing countries where different surgical techniques are used.
Limitations
The study was terminated early, and not all follow-up procedures were complete, which may affect the total number of reported cases.
Participant Demographics
Patients from 24 ophthalmology units and eye clinics across several European countries.
Statistical Information
P-Value
0.002
Confidence Interval
95% CI 1.74–12.08
Statistical Significance
p=0.002
Want to read the original?
Access the complete publication on the publisher's website